Acasti Pharma
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $11,301,000.
Profit Margin
| 2010 | 0 | -1.50M | |
|---|---|---|---|
| 2011 | 29.04K | -2.42M | -8356.62% |
| 2012 | 127.11K | -6.53M | -5143.93% |
| 2015 | 216.28K | -1.32M | -611.47% |
| 2016 | 27.78K | -4.66M | -16774.92% |
| 2018 | 0 | -16.94M | |
| 2019 | 0 | -43.86M | |
| 2021 | 196K | -19.67M | -10039.8% |
| 2022 | 0 | -9.81M | |
| 2024 | 0 | -12.85M |
ACST Income Statement (2010 – 2023)
| 2023 | 2021 | 2020 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 196K | 0 | 0 | 27.78K | 216.28K | 127.11K | 29.04K | 0 |
Cost of revenue | 11K | 15.58M | 76K | 2.33M | 0 | 60.08K | 187.89K | 5.10K | 0 | 0 |
Gross profit | -11K | -15.58M | 120K | -2.33M | 0 | -32.29K | 28.39K | 122.00K | 29.04K | 0 |
Operating exp. | ||||||||||
Research and development | 4.62M | 5.55M | 4.17M | 28.73M | 12.13M | 5.45M | 5.21M | 3.15M | 1.46M | 1.12M |
Selling and marketing | -252K | 518K | 1.14M | 660 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 11.30M | 15.34M | 10.83M | 32.97M | 15.25M | 7.06M | 9.93M | 6.67M | 2.46M | 1.53M |
Operating income | -11.31M | -15.58M | -10.71M | -33.71M | -15.25M | -7.09M | -9.90M | -6.55M | -2.43M | -1.53M |
Other income (expenses), net | -4.61M | 5.12M | -11.26M | -4.90M | -1.40M | 2.43M | 8.25M | 11.97K | 0 | 11.39K |
Income before tax | -14.63M | -10.46M | -19.67M | -38.62M | -16.65M | -4.66M | -1.32M | -6.53M | 0 | 0 |
Income tax expense | -1.77M | -648K | -127K | 5.24M | 291.15K | -2.37M | -8.51M | 0 | 0 | 0 |
Net income | -12.85M | -9.81M | -19.67M | -43.86M | -16.94M | -4.66M | -1.32M | -6.53M | -2.42M | -1.50M |
Earnings per share | ||||||||||
Basic EPS | -1.35 | -1.6 | -7.96 | -6.46 | -7.75 | -20.99 | -5.98 | -8.04 | -4.04 | -5.27 |
Diluted EPS | -1.35 | -1.6 | -7.96 | -6.46 | -7.75 | -20.99 | -5.98 | -8.04 | -4.04 | -5.27 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |